Director, Quality, Early Development Risk Management Head @ (October 2023 - April 2025)
Associate Director, Quality, Early Development Head @ (November 2020 - October 2023)
Associate Director, Quality, Early Development Program Lead @ (January 2019 - June 2021)
Manager, QA Auditing @ (January 2015 - January 2019)
Manager, Quality Monitoring and Compliance @ (June 2013 - January 2015)
Program Manager, Clinical Quality Assurance @ (September 2012 - June 2013)
Sr. Specialist, Therapeutic Area Clinical QA @ (June 2009 - September 2012)
Sr. Specialist, Computer Systems QA @ (March 2008 - June 2009)
Sr. Specialist, Global Clinical QA @ (October 2005 - March 2008)
Sr. Associate, Preclinical QA @ (June 2001 - October 2005)
Patrick Dalton Education
Temple University
M.S. (QA/RA)
2001-2006
University of Scranton
B.S. (Biology)
1995-1999
Patrick Dalton Skills
GxP
21 CFR Part 11
CAPA
Change Control
GCP
FDA
GLP
Sop
Validation
GMP
Computer System Validation
Regulatory Affairs
Clinical Trials
Pharmaceutical Industry
CRO
Quality System
Clinical Research
Biotechnology
Quality Auditing
Trend Analysis
Metrics Reporting
Regulatory Requirements
Regulatory Submissions
Pharmacovigilance
CTMS
Biopharmaceuticals
Drug Development
Clinical Development
Quality Assurance
ICH-GCP
U.S. Title 21 CFR Part 11 Regulation
Ich Gcp
Computer System
Patrick Dalton Summary
Patrick Dalton, based in Easton, PA, US, is currently a Director, Oncology Clinical Risk Management, Hematology at Johnson & Johnson Innovative Medicine. Patrick Dalton brings experience from previous roles at Johnson & Johnson Innovative Medicine. Patrick Dalton holds a 2001 - 2006 M.S. in QA/RA @ Temple University. With a robust skill set that includes GxP, 21 CFR Part 11, CAPA, Change Control, GCP and more. Patrick Dalton has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Patrick Dalton?
Find contact details for 700 million professionals.